CareLit Fachartikel

Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: First-in-Human Results, Biodistribution and Preliminary Dosimetry Estimations

RP Baum, C Smerling, C Schuchardt, A Singh, A Eismant, A Mishra, D Müller, D Zboralski, F Osterkamp, A Höhne, U Reineke, HR Kulkarni · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02

Dokument
1214663
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
RP Baum, C Smerling, C Schuchardt, A Singh, A Eismant, A Mishra, D Müller, D Zboralski, F Osterkamp, A Höhne, U Reineke, HR Kulkarni
Ausgabe
Heft 02 / 2020
Jahrgang 59
Seiten
–
Erschienen: 2020-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0040-1708131

Zusammenfassung

Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: First-in-Human Results, Biodistribution and Preliminary Dosimetry Estimations

Schlagworte

Peptide-Targeted Radionuclide Therapy Using Lu-177 Fap-2286 Diverse Adenocarcinomas First-In-Human Results Biodistribution Preliminary Nuklearmedizin - NuclearMedicine